Trader Note — 9789 total
Boston Scientific heads into the summer with a notable divide: directors bought the stock on the dip last week while short sellers have quietly doubled their position over the past month. The insider angle is the…
BXP, Inc. heads into the summer with shorts unwinding and analysts pruning their price targets, creating a pull between improving near-term positioning and a Street that still sees limited upside. Short interest has…
BWA is up 21% in a month, touched a new 52-week high this week, and just announced a $100 million factory expansion in North Carolina. The tension: every senior executive who could sell has been selling. The insider…
BA has stabilised after last week's sharp sell-off, gaining 1.8% on the week to $218.90 — but the more interesting development is happening in the options market, where sentiment has shifted more decisively toward…
BioCryst Pharmaceuticals enters late May with short sellers holding a firm grip — and the cost to maintain that position just jumped sharply. Short interest is running near 18% of the free float, a level that has…
Best Buy heads into its Q1 2026 results on May 28 with the stock up 6.6% on the week but short sellers refusing to blink — a genuine tension between price momentum and still-elevated bearish positioning. Short interest…
BNS heads into the post-earnings session having delivered exactly what income investors were looking for: a Q2 beat and a dividend raise that arrived on the same morning shorts were quietly building positions to a…
BMO enters the post-earnings stretch with shorts nearly gone, borrow costs at rock bottom, and the stock nudging a 52-week high — the question now is whether the valuation re-rating has further to run. The positioning…
Bank of America closes the week on a very different note from the last: up 3% to $52.20, reversing the month-long grind lower flagged in the prior note and narrowing — though not closing — the gap to analyst…
AutoZone delivered its fiscal Q3 results on May 26 and the market's verdict was swift: the stock dropped 9% the next day to $3,100, extending a monthly decline that now stands at 13%. The analyst response has been…
Applied Materials has surged into a fork in the road: an 11.8% weekly rally to $454.89 has reignited bullish conviction across the Street, yet one bellwether firm just stepped to the sidelines at the very moment…
Amgen heads into the summer with a quietly shifting setup — options traders are more cautious than they've been in months, short interest has been creeping higher for weeks, and the analyst community is clustered just…
Amazon enters the final days of May with options traders at their most bullish in nearly a year, while the Street's price target implies roughly 18% upside from current levels — a gap that keeps the stock interesting…
Agilent Technologies exits earnings week with the recovery story now being tested against an actual result — and the Street is adding fresh endorsements even before the dust settles. The most notable development this…
AMD has done in one week what the Street spent a month arguing it would eventually do: it has raced through the consensus price target. The reversal is the defining story of this note. Seven days ago, AMD closed at…
Adobe Inc. enters its June 11 earnings window with a notable short rebuild underway, a cautious analyst community, and a stock trading nearly 40% below the Street's mean target — a gap that raises more questions than…
Abercrombie & Fitch enters its Q1 2026 earnings release — confirmed for June 3 — with the stock down 14% over the past month, yet options traders have quietly shifted to their most constructive posture in months, even…
Abbott Laboratories is down nearly 5% over the past month to $86.67, but company insiders and the Street's bulls are treating the decline as an entry point — even as the options market quietly rotates more bullish than…
ACNB heads into the last week of May having delivered the strongest monthly price gain in its recent history, with the stock up 12% in a month to $55.06 — and the catalyst is unambiguous: a $0.92 special dividend…
POET Technologies has spent the past week unwinding the extreme short-side pressure that defined mid-May — but with the stock down 8.5% on Tuesday alone to $13.35, the unwind is not yet a clean story. The short…
